February 3rd, 2021SALT LAKE CITY— February 3, 2021. Transit Scientific today announced the close of its Series A financing round. The round was led by a large multinational investor and joined by previous seed investors. Transit Scientific achieved FDA clearances and multi-center, multi-user, safe-patient-use of its XO Score® angioplasty...